跳至主要内容
临床试验/NCT04276220
NCT04276220已完成不适用

Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis Among Patients Undergoing Carpal Tunnel Release Surgery - A Prospective Study

Steen Hvitfeldt Poulsen2 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
109
试验地点
2
主要终点
Prevalence of wild-type transthyretin cardiac amyloidosis in patients undergoing surgery for idiopathic Carpal Tunnel Syndrome Surgery where biopsies from transverse carpal ligament stain positive for amyloid.

研究概览

简要总结

Patients above the age of 60 will be recruited at their carpal tunnel release surgery. Biopsies will be taken from the wrist and examined for the presence of amyloid protein. A amyloid-positive biopsy will refer the patients for cardiac examination including blod- and urine samples examined for transthyretin.

If the result of the cardiac examination is suspected cardiac amyloidosis, the patient will be referred for a diagnostic TC99-DPD scintigraphy. If the scintigraphy is positive, the patient will be referred for right heart catherization (RHC) and an exercise test.

Myocardial biopsies will be taken at the RHC and examined with electron microscopy and high resolution respirometry.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males above 65 years of age, females above 75 years of age.
  • Scheduled idiopathic carpal tunnel release surgery.
  • Informed written consent.

排除标准

  • Operation by other indication, e.g.
  • Known amyloidosis

结局指标

主要结局

Prevalence of wild-type transthyretin cardiac amyloidosis in patients undergoing surgery for idiopathic Carpal Tunnel Syndrome Surgery where biopsies from transverse carpal ligament stain positive for amyloid.

时间窗: Through study completion, 6 years.

We will examine the amyloid deposits prevalence in biopsies from the Carpal Tunnel and ATTRwt prevalence in an aged and predominantly male population operated for idiopathic Carpal Tunnel Syndrom. Diagnosis of wild-type cardiac amyloidosis will be determined by TC99-DPD scintigraphy, endomyocardial biopsy, or both. Biopsies will be examined using Congo Red staining and fluorescent light

次要结局

  • Comparing patients diagnosed with wild-type transthyretin cardiac amyloidosis due to screening with age and gender matched clinically diagnosed ATTRwt patients.(Through study completion, 6 years.)
  • Levels of transthyretin in blood and urine from patients with suspected wild-type transthyretin cardiac amyloidosis(Has been added after study start, will run through study completion, 3 years.)

研究者

发起方
Steen Hvitfeldt Poulsen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Steen Hvitfeldt Poulsen

Professor, DMSc

Aarhus University Hospital Skejby

研究点 (2)

Loading locations...

相似试验